Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yoshifumi Saisho. (2015) Alogliptin benzoate for management of type 2 diabetes. Vascular Health and Risk Management 11, pages 229-243.
Read now
Read now
Sri Harsha Tella & Marc S Rendell. (2015) DPP-4 inhibitors: focus on safety. Expert Opinion on Drug Safety 14:1, pages 127-140.
Read now
Read now
Annalisa Capuano, Liberata Sportiello, Maria Ida Maiorino, Francesco Rossi, Dario Giugliano & Katherine Esposito. (2013) Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin. Drug Design, Development and Therapy 7, pages 989-1001.
Read now
Read now
Andre Scheen. (2013) Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis. Expert Opinion on Drug Safety 12:4, pages 545-557.
Read now
Read now
André J. Scheen. (2013) Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes. Postgraduate Medicine 125:3, pages 7-20.
Read now
Read now
Julia Kenkre, Tricia Tan & Stephen Bloom. (2013) Treating the obese diabetic. Expert Review of Clinical Pharmacology 6:2, pages 171-183.
Read now
Read now
Articles from other publishers (12)
Daniela Istrate & Luminita Crisan. (2023) Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes Mellitus Management: Pharmacophore Virtual Screening, Molecular Docking, Pharmacokinetic Evaluations, and Conceptual DFT Analysis. Processes 11:11, pages 3100.
Crossref
Crossref
Kunika Saini, Smriti Sharma & Yousuf Khan. (2023) DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Ziqi Chen, Bo Peng, Vassilis N. Ioannidis, Mufei Li, George Karypis & Xia Ning. (2022) A knowledge graph of clinical trials ($$\mathop {\mathtt {CTKG}}\limits$$). Scientific Reports 12:1.
Crossref
Crossref
Shuangshuang Zhang, Ruixue Gan, Ludan Zhao, Qiaomei Sun, Hongzhao Xiang, Xi Xiang, Gang Zhao & Hui Li. (2021) Unveiling the interaction mechanism of alogliptin benzoate with human serum albumin: Insights from spectroscopy, microcalorimetry, and molecular docking and molecular dynamics analyses. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 246, pages 119040.
Crossref
Crossref
Hani Naseef, Ramzi Moqadi & Moammal Qurt. (2018) Development and Validation of an HPLC Method for Determination of Antidiabetic Drug Alogliptin Benzoate in Bulk and Tablets. Journal of Analytical Methods in Chemistry 2018, pages 1-7.
Crossref
Crossref
Michael C. Mathers, Sommer D. Zarbock & Emily E. Sutton. (2013) New and Future Medications for the Treatment of Type 2 Diabetes Mellitus. American Journal of Lifestyle Medicine 8:4, pages 260-280.
Crossref
Crossref
Uche Anadu NdefoOkwuchukwu OkoliGoldina Erowele. (2014) Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus. American Journal of Health-System Pharmacy 71:2, pages 103-109.
Crossref
Crossref
Sri Harsha Tella, Halis Kaan Akturk & Marc Rendell. (2014) Linagliptin for the treatment of Type 2 diabetes. Diabetes Management 4:1, pages 85-101.
Crossref
Crossref
Asres Berhan & Yifru Berhan. (2013) Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies. BMC Endocrine Disorders 13:1.
Crossref
Crossref
Belén Picatoste, Elisa Ramírez, Alicia Caro-Vadillo, Cristian Iborra, Jesús Egido, José Tuñón & Óscar Lorenzo. (2013) Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms. PLoS ONE 8:10, pages e78330.
Crossref
Crossref
Baptist Gallwitz. (2013) Incretin for the continuing treatment of secondary failure to metformin in Type 2 diabetes. Diabetes Management 3:4, pages 323-331.
Crossref
Crossref
Eiji Kutoh & Hiroshi Yamashita. (2012) Differential effects on metabolic parameters between sitagliptin and alogliptin in drug naïve subjects with type 2 diabetes. Journal of Diabetes Research and Clinical Metabolism 1:1, pages 17.
Crossref
Crossref